{"id":1116,"date":"2026-03-12T07:00:23","date_gmt":"2026-03-12T07:00:23","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmjleader\/?p=1116"},"modified":"2026-03-10T11:48:39","modified_gmt":"2026-03-10T11:48:39","slug":"clinicians-as-inventors-what-microsurgery-teaches-us-about-nhs-innovation-by-allan-ponniah","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjleader\/2026\/03\/12\/clinicians-as-inventors-what-microsurgery-teaches-us-about-nhs-innovation-by-allan-ponniah\/","title":{"rendered":"Clinicians as inventors: what microsurgery teaches us about NHS innovation. By Allan Ponniah"},"content":{"rendered":"

Microsurgery is not a niche specialism. It underpins cancer reconstruction, trauma care, and the treatment of conditions affecting patients across every demographic.<\/span><\/p>\n

Every day, surgeons perform one of the most technically demanding procedures in modern medicine: repairing blood vessels smaller than a matchstick head, under a microscope, by hand, with sutures finer than human hair. The margin for error is measured in fractions of a millimetre. The consequences of failure, tissue death, limb loss, failed reconstruction, are immediate and irreversible.<\/span><\/p>\n

Despite major advances in robotics, imaging and digital surgery, microsurgery remains one of the most manual parts of modern surgery. The challenge is uniquely complex.<\/span><\/p>\n

The way surgeons connect blood vessels today is still remarkably similar to how it was done in 1902. Instruments are better and imaging is sharper, but the core technique has barely changed.<\/span><\/p>\n

For NHS leaders, this highlights a wider issue. Some clinical problems cannot be solved by applying existing technologies alone. They require invention, developing new approaches shaped around specific clinical problems.<\/span><\/p>\n

Plastic surgery as problem solving<\/b><\/p>\n

Plastic surgery is often misunderstood. At its core, it is about restoring form and function, rebuilding tissue after cancer surgery, injury or genetic conditions.<\/span><\/p>\n

That work is inherently problem solving. Surgeons routinely ask how something can be rebuilt, what tissue can be used, and how it can be kept alive.<\/span><\/p>\n

Microsurgery is the most demanding expression of this thinking. Success depends on visibility, alignment, blood flow, timing, assistance and monitoring. These elements are interdependent, and small changes in one part of the system can affect the whole. It is a system that must work reliably under pressure.<\/span><\/p>\n

This helps explain why progress has been slow. You can optimise individual elements, but if the system fails, the outcome fails.<\/span><\/p>\n

The limits of incremental innovation<\/b><\/p>\n

Over the past century, progress in microsurgery has largely been incremental, including better microscopes, finer instruments, and improved planning and monitoring.<\/span><\/p>\n

These advances matter, but they improve individual components rather than changing the system. In a field where outcomes depend on multiple elements working together, improving parts in isolation rarely delivers step change.<\/span><\/p>\n

Robotic surgery illustrates this well. It has transformed some specialties by solving problems of access, precision and ergonomics. In microsurgery, it has not yet addressed the most critical constraints. If it had, it would already be widely used.<\/span><\/p>\n

This is not a reluctance to adopt. It reflects a mismatch between available technologies and the realities of microsurgical practice, and the lack of systems to embed them safely and consistently.<\/span><\/p>\n

The real barrier is not ideas, but pathways<\/b><\/p>\n

This challenge extends beyond microsurgery.<\/span><\/p>\n

Across the NHS, clinicians identify problems every day through direct patient care. They are often best placed to see what needs to change. Yet innovation is frequently developed externally and introduced into the NHS, rather than emerging from within it.<\/span><\/p>\n

Alongside clinical work, many clinicians lack the time or headspace to develop ideas. Promising solutions encounter fragmented data access, complex governance, and procurement processes that vary between trusts. Innovations can spend years in pilot mode, proving they work in one place but never scaling.<\/span><\/p>\n

From the frontline, this is not a lack of motivation. It is a system that does not consistently support ideas to move beyond early testing.<\/span><\/p>\n

Supporting clinician led invention<\/b><\/p>\n

Many clinicians already think like inventors. What they often lack is structure.<\/span><\/p>\n

Not every clinician needs to become an entrepreneur. But many want to shape solutions, collaborate with engineers and computer scientists, and ensure technologies are grounded in real patient care.<\/span><\/p>\n

To do that well, clinicians need protected time, multidisciplinary teams, and access to environments where ideas can be tested and developed. This includes support with evaluation, governance, commercialisation and implementation. Without this, progress depends on individual effort, and promising work struggles to move beyond isolated pilots.<\/span><\/p>\n

In a system under significant workforce pressure, this matters. It affects how clinical expertise is used and whether innovation translates into meaningful improvements for patients.<\/span><\/p>\n

Building pathways, not just pilots<\/b><\/p>\n

Partnerships with organisations such as UCLPartners can help address this.<\/span><\/p>\n

Rather than starting with technologies, the focus is on shared challenge setting with clinicians, understanding real problems at the point of care. From there, ideas can be explored in structured environments, with early attention to feasibility, evidence, governance and economic impact.<\/span><\/p>\n

Working across multiple NHS trusts can reduce duplication, speed up learning and give innovators clearer routes to scale. It also increases the likelihood that solutions which genuinely improve care are adopted, rather than remaining as isolated demonstrations.<\/span><\/p>\n

Repeated pilots without routes to scale risk consuming time and goodwill without delivering lasting impact.<\/span><\/p>\n

What the microsurgery hackathon shows<\/b><\/p>\n

The robotic microsurgery hackathon held at the Royal Free Hospital in January 2026, offers a practical example of how this approach begins.<\/span><\/p>\n

Surgeons, engineers, AI specialists and students came together to define problems, explore feasibility, and test ideas early. Teams explored approaches including AI, automation and biomaterials to rethink how vessels could be connected.<\/span><\/p>\n

Some focused on improving existing techniques. Others asked more fundamental questions. If we were starting again today, would we still connect blood vessels in the same way?<\/span><\/p>\n

The value of this work is not the prototype alone. It is the pathway that follows, from early concept to further development and testing.<\/span><\/p>\n

Looking forward<\/b><\/p>\n

A century ago, plastic surgery advanced rapidly because necessity demanded it.<\/span><\/p>\n

Today, the NHS faces rising demand, workforce challenges and constrained resources. The need to rethink how problems are solved remains. At a time when the NHS is under pressure to improve productivity and deliver more with limited capacity, this gap matters.<\/span><\/p>\n

Microsurgery shows where incremental innovation reaches its limits. Progress depends not only on better tools, but on how ideas are supported, tested and taken forward.<\/span><\/p>\n

If clinicians are expected to contribute to innovation alongside delivering care, they need structures that make this feasible. This means partnerships that bring engineering, evaluation and translation expertise together, and clearer routes from early ideas to real world use.<\/span><\/p>\n

Progress will not come from technology alone. It will come from clinicians and engineers working together, supported by systems that move good ideas into everyday care.<\/span><\/p>\n

Author<\/strong><\/p>\n

Allan Ponniah<\/strong><\/p>\n

\"Headshot<\/p>\n

Allan is a Consultant Plastic Surgeon at the Royal Free London NHS Foundation Trust, specialising in complex facial reconstruction and skin cancer. His work focuses on restoring function for patients with challenging reconstructive needs.<\/p>\n

Alongside his clinical practice, Allan has a strong interest in surgical innovation and the role of clinician-led invention in improving patient care. Through his work, he explores how healthcare systems can better support clinicians to identify unmet needs, develop new solutions and translate ideas into real-world practice. His perspective sits at the intersection of surgery, innovation and system leadership within the NHS.<\/p>\n

Declaration of Interests<\/strong><\/p>\n

Allan is a consultant plastic surgeon at the Royal Free London NHS Foundation Trust and has a professional interest in surgical innovation and clinician-led invention. He declares no financial conflicts of interest related to this article.<\/p>\n","protected":false},"excerpt":{"rendered":"

Microsurgery is not a niche specialism. It underpins cancer reconstruction, trauma care, and the treatment of conditions affecting patients across every demographic. Every day, surgeons perform one of the most technically demanding procedures in modern medicine: repairing blood vessels smaller than a matchstick head, under a microscope, by hand, with sutures finer than human hair. […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":525,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1116","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/posts\/1116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/users\/525"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/comments?post=1116"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/posts\/1116\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/media?parent=1116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/categories?post=1116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjleader\/wp-json\/wp\/v2\/tags?post=1116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}